Drug Shortage Report for S.O.S. NALOXONE HYDROCHLORIDE INJECTION
Report ID | 3826 |
Drug Identification Number | 02453258 |
Brand name | S.O.S. NALOXONE HYDROCHLORIDE INJECTION |
Common or Proper name | NALOXONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | NALOXONE HYDROCHLORIDE |
Strength(s) | 0.4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 X 1ML AMPOULES |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-04-07 |
Actual start date | |
Estimated end date | 2017-06-16 |
Actual end date | 2017-05-01 |
Shortage status | Resolved |
Updated date | 2017-06-26 |
Company comments | Stock available at some wholesalers/Inventaire disponible chez certains grossistes |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2017-06-26 | French | Compare |
v6 | 2017-06-26 | English | Compare |
v5 | 2017-04-08 | English | Compare |
v4 | 2017-03-28 | French | Compare |
v3 | 2017-03-28 | English | Compare |
v2 | 2017-03-21 | French | Compare |
v1 | 2017-03-21 | English | Compare |
Showing 1 to 7 of 7